Komori
Annual Securities Report2183Linical Co.,Ltd.Services

Annual Securities Report — FY2025

What Linical Co.,Ltd. reported for the period from 2025-04-01 to 2026-03-31. Filed by 株式会社リニカル

How much it says
61Detailed
What moved here
14named for the first time
Its own wording
33terms
Which filing this is
34/ 34newest
No officer data yetThis company's filings have not been read for officers yet. Nothing is missing from the filings — the roster simply has not been extracted.
The gist

In the current fiscal year (1 April 2025 to 31 March 2026), revenue declined and the Company recorded an operating loss, ordinary loss and net loss attributable to owners of the parent. The filing identifies lower revenue in the United States and Europe, impairment of goodwill related to the European business, and impairment of fixed assets related to the Japanese business as factors contributing to the larger losses.

Komori's summary of this document, not the document's own words.
61Detailed
How much this filing saysA weighted roll-up of 11 rubric dimensions, each scored from a fixed set of questions asked against this filing — built only from the 35 this document could answer. It measures how specific the disclosure is, not whether the company is doing well. Derived from the data, not editorial.
73
Detailed
Magnitude of change
91
Very detailed
Strategic shift
94
Very detailed
Capital movements
62
Detailed
Disclosure Gaps
0
Almost nothing
Concentration Risk
50
Typical
Future commitments
68
Detailed
Change in Risk
55
Typical
Financial and Capital Policy
53
Typical
Product portfolio
55
Typical
Technology Position
50
Typical
Confidence in Strategic Bets
R&D spendNot disclosedThis document does not carry the figure.
Cash left over-11億円Cash from the business, less what went into equipment.
Spent on equipment63百万円Plants, machines — things meant to last.
Employees577Headcount at the end of this period.
How to read this page
This is not the documentIt is Komori's reading of the filing submitted to EDINET. The original is linked above.
The score is not a verdictIt measures how specific the disclosure is. It says nothing about results or where the share price goes.
When it updatesContent lands once the filing has been read through. Right after submission, the summary can still be empty.
Linical Co.,Ltd. — FY2025 | Komori